PEDIATRICS Vol. 99 No. 3 March 1997,
p. e6
Copyright ©1997 by the American Academy of Pediatrics
ELECTRONIC ARTICLE:
Admixture of a Multivitamin Preparation to Parenteral
Nutrition: The Major Contributor to In Vitro Generation of
Peroxides
,
From the * Research Center of Hospital Sainte-Justine and the
Department of Pediatrics, University of Montreal, Montreal, Quebec,
Canada.
Background. Peroxides have been reported to contaminate lipid emulsions and amino acid solutions used in total parenteral nutrition (TPN). This is particularly disturbing in newborn infants who are prone to several diseases related to immature defense mechanisms against oxidative challenges. It is not clear whether the antioxidants in multivitamins help protect parenteral nutrients against the hazards of oxidation.
Objective. To evaluate the role of a multivitamin preparation (MVI) on the actual peroxide load received by patients on TPN.
Methodology. The generation of peroxides in parenteral nutrition was tested first using test solutions. We compared the relative contribution of commercially available amino acid solutions, a lipid emulsion, and MVI on the level of peroxides in clinically relevant TPN solutions. Second, we measured the level of peroxides actually infused at the bedside. In both circumstances, the effects of time and light exposure were isolated. The level of peroxides was determined by a colorimetric technique and expressed as µM equivalents tert-butyl hydroperoxide (µM = TBH).
Results. Even when protected from light, the addition of MVI produced a 10-fold increase in peroxides (mean ± SEM, n = 3, 19 ± 4 to 189 ± 8 µM = TBH at 4 h) in the fat-free TPN solution and a fourfold increase (64 ± 6 to 244 ± 8 µM = TBH at 4 h) in the lipid-containing TPN solution. A dose-response relationship was found between the concentration of MVI and peroxide levels. The effect of light was the strongest in the presence of multivitamins. The amino acid solutions had a relative inhibitory effect on the generation of peroxides by MVI, which varied (from 54 ± 1% to 72 ± 1%) all according to the amino acid blend. In parenterally fed premature infants, protecting the intravenous set from light decreased the load of infused peroxides (146 ± 15 vs 215 ± 24 µM = TBH).
Conclusions. The lipid emulsion had a significant but minor additive effect compared with the multivitamin preparation, which was the major contributor to the generation of peroxides. Protection from photooxidation is not sufficient to prevent peroxidation of TPN solutions. Contrary to what one would expect, increasing the concentration of MVI will lead to a greater generation of peroxides, suggesting that the essential antioxidants in MVI do not have antiperoxide properties. amino acids, antioxidants, detergents, lipids, newborn infants, oxidation, parenteral nutrition.
Isolated constituents of total parenteral nutrition (TPN) represent a potential source of oxidants. Because lipids infused with TPN solutions are contaminated by peroxides,1,2 these emulsions are often believed to be the major source of oxidants in solutions of parenteral alimentation. However, other nutrients can promote peroxidation such as amino acids,3,4 vitamins,5,6 trace metals,7 and additives used for stability.8 But the total peroxide load received by patients on TPN has not been clearly established.
Peroxides are products of oxidation, but they can also become highly reactive oxygen species in the presence of trace metals. Increasing evidence indicates that these sources of oxidants disrupt cell membrane integrity and mediate tissue injury.9 Furthermore, the oxidation can cause changes in the quality of solutions,12 as well as loss of potency of parenteral nutrients, because the concentrations of several vitamins and amino acids decrease in TPN solutions exposed to light.12 In the face of immature antioxidant defenses, infused peroxides have the potential to cause an oxidative challenge with general effects or local repercussions at the site of infusion. This is supported by the demonstration that the infusion of an antiperoxide such as bisulfite was associated in parenterally fed infants with a drop in urinary malondialdehyde,8 a marker of peroxidation13. At the site of infusion, tert-butyl hydroperoxide (TBH) induced an oxidative response in endothelial cells characterized by modifications in prostaglandin and glutathione productions.14
Multivitamin preparations contain several antioxidants such as ascorbate, tocopherol, vitamin A, mannitol, butylhydroxytoluene. Therefore, one would expect the multivitamins to help protect parenteral nutrients against the hazards of oxidation. This is supported by the observation that ascorbate hinders the generation of peroxides in a lipid emulsion.15 These antioxidants act as chain-breaking agents by scavenging peroxyl radicals and reactive oxygen species. Multivitamin preparations also contain molecules associated with the generation of peroxides, such as riboflavin16 and detergents.17 It is not clear whether multivitamins have antiperoxide properties.
The aim of our study was to evaluate the role of a multivitamin preparation on the actual peroxide load received by patients on TPN.
The peroxide-generating capacity of parenteral nutrition was tested first on the bench by comparing the relative contribution of amino acids, lipids, and the multivitamin preparation, as well as by comparing different commercially available amino acid preparations. Second, it was also tested at the bedside.
Test Solutions
The generation of peroxides was compared between different TPN preparations left at darkness or at daylight for 6 h. The tested solutions contained clinically relevant concentrations of individual parenteral nutrients delivered to newborn infants: (a) fat-free and vitamin-free parenteral nutrition (PN) = 2.5% (w/v) amino acids (Travasol 10% Blend C; Clintec Canada, Mississauga, Ontario, Canada) plus 10% (w/v) dextrose plus standard electrolytes and trace elements (Micro + 6 Pediatric, Sabex International, Montreal, Quebec, Canada); (b) PN + LIPIDS = the same as in a, to which the lipid emulsion Intralipid-10% (Pharmacia Inc, Mississauga, Ontario, Canada) was added to obtain a final 5.5% (v/v) concentration; (c) PN + multivitamin preparation (MVI) = the same as in a, to which the multivitamin preparation MVI Pediatric (Rhône Poulenc Rorer, Montreal, Quebec, Canada) was added to obtain a final 1% (v/v) concentration; (d) PN + LIPIDS + MVI = the same as in b, to which the multivitamin preparation MVI Pediatric was added to obtain a final 1% (v/v) concentration. All these solutions were prepared in water to obtain a constant concentration of nutrients. Furthermore, a dose-response relationship was sought between MVI in water and peroxides after 3 h of exposure to daylight.At the Bedside
To verify that the findings in the test solutions were of relevance to patient care, we sought to confirm the presence of peroxides in TPN solutions actually delivered to preterm infants. The effect of protecting the parenteral solution from photooxidation during the transit from the bag to the patient was tested on the peroxide content. The concentrations of amino acid (Blend C) and dextrose were ordered by the attending physician; all solutions were supplemented with standard electrolytes, trace elements (Micro + Pediatric), and 2.5 mL/d multivitamin preparation (MVI Pediatric). According to routine procedures, all bags containing TPN solutions hang at the bedside, protected from light by an opaque plastic cover that is open toward the bottom. Twenty-two hours after infusing fat-free TPN preparations, a sample was taken simultaneously from the bag and from the extension set (Baxter, Toronto, Ontario, Canada) at the closest sampling site to the infant. This procedure was performed in two groups of infants: (1) those fitted with the unprotected extension set according to routine procedures, and (2) those with the same tubing but protected from light with a custom-made opaque plastic sleeve extending from the TPN bag to the infusion pump and from that device to the patient. To ensure similar transit time and experimental conditions in both groups, patients were selected so that the infusion rates were comparable (between 4 and 7 mL/h) and MVI concentrations within a range of 1% to 2.5% (v/v) of final solution.Statistics
The data are presented as the mean ± SEM. Unless otherwise stated, measurements were performed in triplicate. The effects of nutrients, daylight, and duration of exposure were isolated in a 4 × 2 × 2 × 2 (time × LIPID × MVI × light) multifactorial ANOVA. The effect of bisulfite was isolated by comparing Blend C vs TIV. The effects of cysteine and amino acid blends were isolated in a 2 × 2 × 2 multifactorial ANOVA (Blend C ± 500 mg/L cysteine hydrochloride vs Aminosyn ± 500 mg/L cysteine hydrochloride). At the bedside, the effect of daylight on peroxidation was isolated by ANOVA. The level of significance was set at P <.05.Hydroperoxides were detected in newly open bottles of Intralipid-10% (134 ± 16 µM = TBH, n = 6) in the freshly prepared PN solution (16 ± 5 µM = TBH) as well as in newly reconstituted 5-mL vials of MVI (3280 ± 110 µM = TBH). However, the actual peroxide load measured in TPN solutions (Figs 1, 2) reflected the dilution of the original constituents.
Fig. 1. Influence of a lipid emulsion and daylight on peroxide levels in freshly prepared solutions of PN devoid of multivitamins (PN and PN + LIPID). The data represent the mean ± SEM, n = 3; the variations are not depicted because of their small size relative to the symbols. There was a significant difference (P < .001) between PN and PN + LIPID on peroxide content, whereas daylight had no effect (F(1,64) = 0).
[View Larger Version of this Image (26K GIF file)]
Fig. 2. Influence of a lipid emulsion and daylight on peroxide levels in freshly prepared solutions of parenteral nutrition containing multivitamins (PN + MVI and PN + LIPID + MVI). The data represent the mean ± SEM, n = 3; the variations are not depicted because of their small size relative to the symbols. The peroxide content rose significantly over time (P < .001), and exposure to daylight had a significant effect on peroxide generation (P < .001).
[View Larger Version of this Image (25K GIF file)]
Table 1.
Percent of Inhibition of Peroxide Generation by MVI
Fig. 3.
Dose-response relationship between peroxide content and MVI admixture
in PN in water after 3 h of exposure to daylight.
[View Larger Version of this Image (15K GIF file)]
Fig. 4.
Influence of a 24-h exposure to daylight on peroxide content in
preparations with varying amino acid content and constant MVI
concentration (1%) relative to the final volume. The data represent
the mean ± SEM, n = 3; the variations are not depicted because of their small size relative to the symbols. Despite a constant
MVI content, peroxide generation was inhibited by increasing amino acid
concentrations, suggesting a protective effect.
[View Larger Version of this Image (17K GIF file)]
Fig. 5.
Comparison of peroxide concentrations (µM = TBH) measured
in actual fat-free TPN solutions being delivered to premature infants. Values (mean ± SEM, n = 6) represent peroxides sampled in
the bag of TPN or in the extension set close to the infant. Two groups of six infants were studied while on comparable TPN regimens; those
with extension sets protected from light received a significantly lower
infusion of peroxides.
[View Larger Version of this Image (21K GIF file)]
The important findings of this study are that the multivitamin
preparation is the major contributor to in vitro
peroxidation and that commercially available amino acid preparations
offer some degree of protection in the final solution. Our measurements were validated previously by recovery of externally added peroxides such as TBH, H2O2, and cumen
peroxide,8 and furthermore, we found in Intralipid-10%
peroxide levels that were in the same range as those reported for the
10% lipid emulsion Liposyn1 despite differing analytical
techniques. This is further supported by the drop in peroxide content
after catalase or bisulfite admixture.
Received for publication Jun 17, 1996; accepted Oct 3, 1996.
Address correspondence to: Philippe Chessex, MD, Research Center of Hospital Sainte-Justine, 3175 Chemin Côte Sainte-Catherine, Montreal, Quebec, Canada H3T 1C5.
This work was supported by a grant from The Hospital for Sick Children Foundation, Toronto, Ontario, Canada.
We wish to thank Jocelyne Vallée, RN, for her help in collecting the samples at the bedside. Clintec Canada and Abbott Laboratories provided the amino acid solutions used in this study.
TPN, total parenteral nutrition. TBH, tert-butyl hydroperoxide. PN, fat-free and vitamin-free parenteral nutrition. MVI, multivitamin preparation.
-
Helbock HJ,
Motchnik PA,
Ames BN
Toxic hydroperoxides in
intravenous lipid emulsions used in preterm infants.
Pediatrics.
1993;
91:83-88 [Medline]
[Abstract/Free Full Text] - Pitkänen O, Hallman M, Anderson S Generation of free radicals in lipid emulsion used in parenteral nutrition. Pediatr Res. 1991; 29:56-59 [Medline]
- Gebicki S, Gebicki JM Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem J. 1993; 289:743-749 [Medline]
- Wang RJ, Nixon BT Identification of hydrogen peroxide as a photoproduct toxic to human cells in tissue-culture medium irradiated with "daylight." In Vitro. 1978; 14:715-722 [Medline][Medline]
- Link G, Pinson A, Kahane I, Hershko C Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid peroxidation. J Lab Clin Med 1989; 114:243-249 [Medline][Medline]
- Brawley V, Bhatia J, Karp WB Hydrogen peroxide generation in a model pediatric parenteral amino acid solution. Clin Sci. 1993; 85:709-712[Medline]
- Machlin LJ, Bendich A Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1987; 1:441-445 [Medline][Abstract]
- Lavoie JC, Lachance C, Chessex P Antiperoxide activity of sodium metabisulfite: a double-edged sword. Biochem Pharmacol. 1994; 47:871-876 [Medline][CrossRef][Medline]
- Lunec J Free radicals: their involvement in disease process. Ann Clin Biochem. 1990; 27:172-182
- Kennedy K Dietary antioxidants in the prevention of oxygen-induced injury. Semin Perinatol. 1989; 13:97-103 [Medline][Medline]
- Pitkänen OM Peroxidation of lipid emulsions; a hazard for the premature infant receiving parenteral nutrition? Free Radic Biol Med 1993; 13:239-245
- Bhatia J, Mims LC, Roesel RA The effect of phototherapy on amino acid solutions containing multivitamins. J Pediatr. 1980; 96:284-286 [Medline][CrossRef][Medline]
- Dhanakoff SN, Draper HH Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo. Lipids. 1987; 22:643-646[Medline]
- Lavoie JC, Chessex P Gender-related response to a tert-butyl hydroperoxide-induced oxidation in human neonatal tissue. Free Radic Biol Med 1994; 16:307-313 [Medline][CrossRef][Medline]
- Neuzil J, Darlow BA, Inder TE, Sluis KB, Winterbourn CC, Stocker R Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feeding. J Pediatr. 1995; 126:785-790 [Medline][CrossRef][Medline]
-
Bhatia J,
Stegink LD,
Ziegler EE
Riboflavin enhances photo-oxidation
of amino acids under simulated clinical conditions.
J Parenter
Enter Nutr.
1983;
7:277-279
[Abstract/Free Full Text] - Ding S Quantitation of hydroperoxides in the aqueous solutions of non-ionic surfactants using polysorbate 80 as the model surfactant. J Pharm Biochem Anal. 1993; 2:95-101
- White W, Stabler SP, Alle RH, Moreland S, Rosenberg AA Plasma cysteine concentrations in infants with respiratory distress. J Pediatr. 1994; 125:769-777[CrossRef][Medline]
- Jiang ZY, Woollard ACS, Wolff SP Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids. 1991; 26:853-856 [Medline][Medline]
- Jaeger J, Sorensen K, Wolff SP Peroxide accumulation in detergents. J Biochem Biophys Methods. 1994; 29:77-81 [Medline][CrossRef][Medline]
-
Bove KE,
Kosmetatos N,
Wedig K,
Frank DJ,
Whitlach S,
Saldivar V,
Haas J,
Bodenstein C,
Balistreri WF
Vasculopathic hepatotoxicity associated
with E-Ferol syndrome in low-birth-weight infants.
JAMA.
1985;
254:2422-2430 [Medline]
[Abstract/Free Full Text] -
Lorch V,
Murphy D,
Hoersten LR,
Harris E,
Fitzgerald J,
Sinha S
Unusual syndrome among premature infants: association with a new
intravenous Vitamin E product.
Pediatrics.
1985;
75:598-602 [Medline]
[Abstract/Free Full Text] - Roos D, Weening RS, Votema AA Protection of human neutrophils against oxidative damage. Agents Actions. 1980; 10:528-535 [Medline][CrossRef][Medline]
- Fuortes M, Nathan C. Role of CD11/CD18 integrins and cAMP in the TNF-induced respiratory burst of human neutrophils. In: Jesaitis AJ, Dratz EA, eds. The Molecular Basis of Oxidative Damage by Leukocytes. Ann Arbor: CRC Press; 1992:81-90
- Runge-Morris M, Frank P, Novak RF Differential effects of organic hydroperoxides and hydrogen peroxide on proteolysis in human erythrocytes. Chem Res Toxicol. 1989; 2:76-83 [Medline][CrossRef][Medline]
- Rickett M, Kelly FJ Developmental expression of antioxidant enzymes in guinea pig lung and liver. Development. 1990; 108:331-336[Abstract]
-
Shattuck KE,
Bhatia J,
Grinnell C,
Rassin DK
The effects of light
exposure on the in vitro hepatic response to an amino acid-vitamin
solution.
J Parenter Enter Nutr.
1995;
19:398-402
[Abstract/Free Full Text]
Pediatrics (ISSN 0031 4005). Copyright ©1997 by the American Academy of Pediatrics
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






